- A pilot clinical study of D9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
- Bosy2000_HempSeedOilTesting
- Constantino1997_PosTHC_HempSeed
- Russo_A tale of two cannabinoids
- Activity of cannabis in relation to its delta’-trans-tetrahydro-cannabinol content
- Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats
- Antibacterial activity of D9_tetrahydrocannabinol and cannabidiol
- Antidepressant-like effect of D9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L
- BRONCHODILATOR EFFECT OF D9-TETRAHYDROCANNABINOL
- Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
- Cannabidiol Attenuates the Appetitive Effects of D9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- Cannabidiol Enhances the Inhibitory Effects of D9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
- Consumption and Quantitation of D9-Tetrahydrocannabinol in Commercially Available Hemp Seed Oil Products
- Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
- D9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
- Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol
- Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults
- Antibacterial activity of D9_tetrahydrocannabinol and cannabidiol
- Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for D9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- Histone Modifications Are Associated with Delta (9)-tetrahydrocannabinol-Mediated Alterations in Antigen-Specific T Cell Responses
- Influence of Treatment of Tourette Syndrome with D9-Tetrahydrocannabinol (D9-THC) on Neuropsychological Performance
- Long_term behavioral and biochemical effects of an ultra_low dose of D9_tetrahydrocannabinol (THC)- neuroprotection and ERK signaling
- Marijuana, Tetrahydrocannabinol, and Pulmonary Antibacterial Defenses
- Neuroprotection by D9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
- Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity
- Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- Preliminary, open-label, pilot study of add-on oral D9-tetrahydrocannabinol in chronic post-traumatic stress disorder
- Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids- Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
- The endocannabinoid system and emotional Processing- A pharmacological fMRI study with D9-tetrahydrocannabinol
- Treatment of Tourette-Syndrome with D9-Tetrahydrocannabinol (THC)- a randomized crossover trial
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.